Dr. Vaibhav Sahai is an Associate Professor of Internal Medicine and Section Head of Gastrointestinal Oncology in the Division of Hematology and Oncology at the University of Michigan in Ann Arbor, Michigan. His translational lab research program leverages the pancreaticobiliary cancer biobanks that he directs for the therapeutic investigation of novel compounds in patient-derived biliary cell lines and organoid models to help develop novel phase 1/2 investigator-initiated clinical trials. As a clinical investigator, he is the principal investigator on several investigator-initiated multi-institutional clinical trials open across the U.S.